Bioaxial secures funds
Bioaxial has secured $2.7 million in new funding to finance the commercialization of its first range of super-resolved fluorescence microscopy instruments. Investors include Amorcage Technologique Investissement (a fund managed by CEA Investissement), Inserm Transfert Initiative and Viveris Management plus a range of individual investors.
27 November 2013•4 mins read
